학술논문

111 - Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience.
Document Type
Article
Source
Lung Cancer (01695002). Jun2021:Supplement 1, Vol. 156, pS46-S46. 1p.
Subject
*PEMBROLIZUMAB
*NON-small-cell lung carcinoma
*METASTASIS
Language
ISSN
0169-5002